nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients
|
Maschmeyer, G. |
|
|
20 |
9 |
p. 1560-1564 |
artikel |
2 |
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
|
Rabaglio, M. |
|
|
20 |
9 |
p. 1489-1498 |
artikel |
3 |
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|
Di Lorenzo, G. |
|
|
20 |
9 |
p. 1535-1542 |
artikel |
4 |
Cetuximab-induced aseptic meningitis
|
Feinstein, T.M. |
|
|
20 |
9 |
p. 1609-1610 |
artikel |
5 |
Dietary vitamin D and cancers of the oral cavity and esophagus
|
Lipworth, L. |
|
|
20 |
9 |
p. 1576-1581 |
artikel |
6 |
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
|
|
|
20 |
9 |
p. 1612 |
artikel |
7 |
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
|
Simmons, C. |
|
|
20 |
9 |
p. 1499-1504 |
artikel |
8 |
Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable disease
|
Jara Sánchez, C. |
|
|
20 |
9 |
p. 1607-1608 |
artikel |
9 |
Early detection of second breast cancers improves prognosis in breast cancer survivors
|
Houssami, N. |
|
|
20 |
9 |
p. 1505-1510 |
artikel |
10 |
Editorial Board
|
|
|
|
20 |
9 |
p. ii-iii |
artikel |
11 |
Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008
|
Cohen, J.I. |
|
|
20 |
9 |
p. 1472-1482 |
artikel |
12 |
Estrogen concentrations in beef and human hormone-dependent cancers
|
Handa, Y. |
|
|
20 |
9 |
p. 1610-1611 |
artikel |
13 |
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial
|
Schoof, N. |
|
|
20 |
9 |
p. 1548-1554 |
artikel |
14 |
Gefitinib for advanced non-small-cell lung cancer and quality of life: expanding and improving treatment options
|
William Jr, W.N. |
|
|
20 |
9 |
p. 1455-1457 |
artikel |
15 |
High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma
|
Ngeow, J.Y.Y. |
|
|
20 |
9 |
p. 1543-1547 |
artikel |
16 |
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour
|
Rikhof, B. |
|
|
20 |
9 |
p. 1582-1588 |
artikel |
17 |
in this issue
|
|
|
|
20 |
9 |
p. 1453 |
artikel |
18 |
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
|
Okines, A.F.C. |
|
|
20 |
9 |
p. 1529-1534 |
artikel |
19 |
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)
|
Ruhstaller, T. |
|
|
20 |
9 |
p. 1522-1528 |
artikel |
20 |
Non-small-cell lung cancer: should histology guide chemotherapy treatment?
|
Bennouna, J. |
|
|
20 |
9 |
p. 1608-1609 |
artikel |
21 |
Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer
|
Hanauske, A.-R. |
|
|
20 |
9 |
p. 1565-1575 |
artikel |
22 |
Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group)
|
Witteveen, P.O. |
|
|
20 |
9 |
p. 1511-1516 |
artikel |
23 |
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel
|
Sekine, I. |
|
|
20 |
9 |
p. 1483-1488 |
artikel |
24 |
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
|
Jarnagin, W.R. |
|
|
20 |
9 |
p. 1589-1595 |
artikel |
25 |
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant
|
Hall, M.J. |
|
|
20 |
9 |
p. 1517-1521 |
artikel |
26 |
Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib
|
Cathomas, R. |
|
|
20 |
9 |
p. 1606-1607 |
artikel |
27 |
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group
|
Debourdeau, P. |
|
|
20 |
9 |
p. 1459-1471 |
artikel |
28 |
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
|
Neyns, B. |
|
|
20 |
9 |
p. 1596-1603 |
artikel |
29 |
Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy
|
Wong, A.L. |
|
|
20 |
9 |
p. 1605-1606 |
artikel |
30 |
Table of Contents
|
|
|
|
20 |
9 |
p. iv-v |
artikel |
31 |
Use of chemotherapy at end of life in oncology patients
|
Kao, S. |
|
|
20 |
9 |
p. 1555-1559 |
artikel |